The Jak/Stat signalling pathway, which is affected by olanzapine treatment, is also known to regulate how muscle mass is lost or gained, which is an essential factor in defining obesity [67]. Here, SOAT1 is linked to obesity due to melanocortin 4 receptor deficiency.